Literature DB >> 7144923

Interaction of calcium with 3H-morphine binding to synaptosomes of the guinea-pig ileum.

F A Opmeer, A Witter, J M van Ree.   

Abstract

Specific binding sites for 3H-morphine were assayed in subcellular fractions of a crude mitochondrial P2 pellet from the guinea-pig ileum longitudinal muscle-myenteric plexus, prepared by discontinuous sucrose-gradient fractionation. The highest specific binding (ca. 100 fmol/mg protein) was obtained in the fraction containing synaptosomes, as examined by electron microscopy. A synaptosomal fraction prepared from guinea-pig brain had comparable specific binding (ca 130 fmol/mg) to that of the ileal synaptosomal fraction. Addition of calcium (10 mM) to the binding assay medium resulted in a marked decrease in particular of the specific 3H-morphine binding. Detailed analysis of the specific 3H-morphine binding. Detailed analysis of the specific 3H-morphine binding in the synaptosomal fraction of the ileum revealed that 1) a saturable component of specific opiate binding was present between 0.34 and 21.74 nM of 3H-morphine; 2) in the presence of 3 and 10 nM of calcium similar decreases of specific 3H-morphine binding were obtained, indicating that this binding was maximally inhibited already by 3 mM of calcium; 3) both in the absence and presence of calcium the KD of specific 3H-morphine binding was about 38 nM, indicating a non-competitive nature of the calcium inhibition; 4) addition of magnesium exhibited a similar effect as that of calcium, although magnesium appeared to be less potent than calcium in this respect. The data are discussed in the context of previously observed calcium effects on opioid actions in the electrically stimulated guinea-pig ileum bioassay and may contribute to the evidence that the interaction of calcium and opioids on the stimulus-release coupling mechanism at the neuromuscular junction of the guinea-pig ileum is occurring beyond opioid receptor activation as well.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7144923     DOI: 10.1007/bf00586340

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance.

Authors:  R A Harris; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

2.  Receptor binding and pharmacological activity of opiates in the guinea-pig intestine.

Authors:  I Creese; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1975-07       Impact factor: 4.030

3.  Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development.

Authors:  R J Hitzemann; B A Hitzemann; H H Loh
Journal:  Life Sci       Date:  1974-06-16       Impact factor: 5.037

4.  Fine structure of the myenteric plexus in the guinea-pig ileum.

Authors:  G Gabella
Journal:  J Anat       Date:  1972-01       Impact factor: 2.610

5.  Stereospecific uptake of narcotic analgesics by a subcellular fraction of the guinea-pig ileum. A preliminary communication.

Authors:  L Terenius
Journal:  Ups J Med Sci       Date:  1973-07       Impact factor: 2.384

Review 6.  Metal ion interactions with opiates.

Authors:  D B Chapman; E L Way
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

7.  Effects of acute and chronic morphine treatments on calcium localization and binding in brain.

Authors:  H Yamamoto; R A Harris; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

8.  Levorphanol inhibition of Ca++ binding to synaptic membranes in vitro.

Authors:  D H Ross; H L Cardenas
Journal:  Life Sci       Date:  1977-04-15       Impact factor: 5.037

Review 9.  Opiate receptors and opioid peptides.

Authors:  S H Snyder; S R Childers
Journal:  Annu Rev Neurosci       Date:  1979       Impact factor: 12.449

10.  Quantification of the in vitro induced tolerance to morphine of the isolated guinea pig ileum.

Authors:  F A Opmeer; J M van Ree
Journal:  Neuropharmacology       Date:  1978-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.